PUBLIC CONTRACT · 2025
Aquisição de DABRAFENIB ORAL 75 MG CAP (AUE 202302160) ao Lab. Astrazeneca para a ULSASI para o ano de 2025
- Contract value
- €52,828.88
- Signed on
- 29 May 2025
- Procedure
- Contratação excluída II
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15253111PUBLISHED SUBJECT
Aquisição de DABRAFENIB ORAL 75 MG CAP (AUE 202302160) ao Lab. Astrazeneca para a ULSASI para o ano de 2025
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ASTRAZENECA - PROD.FARMACEUTICOS, LDA · Tax ID 502942240
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €52,828.88
- Procedure base price
- €52,828.88
- Total effective price
- Not reported on Portal BASE
- Publication date
- 7 July 2026
- Award date
- 29 May 2025
- Signing date
- 29 May 2025
- Performance period
- 216 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Contratação excluída II
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- artigo 5.º n.º 1 do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11210136
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.